Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome
A Comparative, Randomised Controlled Trial for Evaluating the Efficacy of Dexamethasone in the Treatment of Patients With Acute Respiratory Distress Syndrome
Sponsor: Asociación Científica Pulmón y Ventilación Mecánica
This PHASE4 trial investigates Acute Respiratory Distress Syndrome and is currently completed. Asociación Científica Pulmón y Ventilación Mecánica leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Aug 2018 — Mar 2019 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asociación Científica Pulmón y Ventilación Mecánica
- Dr. Negrin University Hospital
- Fundación Mutua Madrileña
For direct contact, visit the study record on ClinicalTrials.gov .